Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Alvimopan improves gastrointestinal transit in POI and chronic constipation

May 25, 2004

Prostaglandins suggested as a potential target in ulcerative colitis

May 25, 2004

Therapeutic benefits of adalimumab in Crohn's disease

May 24, 2004

Potential benefits of SLV-317 in irritable bowel syndrome

May 24, 2004

SciClone meets enrollment objective in phase III hepatitis C trial

May 24, 2004

JYL-1421 and acid stimulation of esophageal afferent neurons in rats

May 24, 2004

Preliminary evidence for the efficacy of basiliximab in ulcerative colitis

May 21, 2004

Positive results reported from phase III trial of alvimopan in opioid-induced bowel dysfunction

May 21, 2004

Therapeutic benefits of sargramostim in moderate to severe Crohn's disease

May 21, 2004

Phase II clinical data on the efficacy of tolevamer in CDAD

May 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...